MKI67 and neoplasm: In the present study, increased expression of Ki67 was observed in the cases of drug-induced (11~19%), Hp infection-induced (14~21%), metaplastic (9~32%), atrophic hyperplasia (18~34%), low-grade neoplasia (26~35%), and high-grade neoplasia (32~40%) (Table 2).